Input comparison
NHS Nebido vs Test Cyp
Cypionate is the admissible timing sketch. Nebido undecanoate remains a named withheld row because Atlas has no defensible Nebido formulation basis.
Withheld Nebido lanes are not a q42 or q84 blood cartoon and are not a medical protocol.
Free · no sign-in · legacy unreviewed half-life basis · inputs remain editable
Protocol A
Administration-window schematic · not model output
What this page models
A 24-week example: twice-weekly testosterone cypionate plus two Nebido schedule lanes.
What stays uncertain
Withheld Nebido lanes are not a q42 or q84 blood cartoon and are not a medical protocol.
Why this curve?
This link explicitly selects Atlas's generic structural timing basis. Atlas combines each selected compound descriptor with the entered dose unit, cadence, administration window, and plot horizon. The live plot reports a normalized, unitless timing shape and exposes the selected basis and evidence status beside the result.
Changed inputs recompute the curve. A changed shape is a model response to changed inputs. It is not a measured concentration or an individual outcome.
Atlas is a research modeling instrument: it reports model-scoped signal indices, not medical advice. See the Terms & disclaimer.